SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity

BACKGROUND: Cancers harboring spliceosome mutations are highly sensitive to additional perturbations on the spliceosome that leads to the development of onco-therapeutics targeting the spliceosome and opens novel opportunities for managing aggressive tumors lacking effective treatment options such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xiaofeng, Cai, Linhan, Zhang, Zhifa, Li, Jitian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126993/
https://www.ncbi.nlm.nih.gov/pubmed/37098488
http://dx.doi.org/10.1186/s12885-023-10860-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126993/
https://www.ncbi.nlm.nih.gov/pubmed/37098488
http://dx.doi.org/10.1186/s12885-023-10860-z

Ejemplares similares